Form 4: Arteris Inc. VP and General Counsel Paul Alpern Reports Stock Transactions
SEC Form 4 Filing
Paul Alpern, VP and General Counsel of Arteris, Inc., reports the acquisition and disposal of common stock and derivative securities, including transactions made under a 10b5-1 trading plan.
Summary
- On March 1, 2024, Paul Alpern, VP and General Counsel of Arteris, Inc., exercised options to acquire 1,250 shares of common stock at $0.60 and 10,000 shares at $0.56.
- Also on March 1, 2024, Alpern sold 10,000 shares at a weighted average price of $7.0792 and 1,250 shares at a weighted average price of $7.0714.
- Further sales occurred on March 4 and 5, 2024, with 296 shares sold at $7.1662 and 386 shares sold at $7.17, respectively.
- These transactions were made pursuant to a 10b5-1 trading plan adopted on August 16, 2023.
- Following these transactions, Alpern beneficially owns 86,839 shares of common stock, including restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 08/26/2020 | 25% of the total shares vested; thereafter, 1/48th of the total shares have vested monthly for 3 years, beginning on September 26, 2020. |
| 07/23/2021 | 25% of the total shares vested; thereafter, 1/48th of the total shares vest monthly for 3 years, beginning on August 23, 2021. |
| 08/16/2023 | Reporting Person adopted a 10b5-1 trading plan. |
| 03/01/2024 | Exercise of stock options and sale of common stock. |
| 03/04/2024 | Sale of common stock. |
| 03/05/2024 | Sale of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.